SCHEMBL3418752

SCHEMBL3418752

CN(C)CCNc1cccc2c1C(=O)c1ccccc1C2=O

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.63
SMN1; SMN2 Q16637 5/20 0.63
MEN1 O00255 5/20 0.63
KMT2A Q03164 5/20 0.63
ALDH1A1 P00352 5/20 0.63
MAPK1 P28482 4/20 0.63
EGFR P00533 3/20 0.63
L3MBTL1 Q9Y468 3/20 0.63
POLB P06746 3/20 0.63
RAD52 P43351 3/20 0.63
BLM P54132 3/20 0.63
LMNA P02545 2/20 0.63
HTT P42858 2/20 0.63
RECQL P46063 1/20 0.63
NPSR1 Q6W5P4 1/20 0.63
MALT1 Q9UDY8 1/20 0.57
TERT O14746 3/20 0.57
TDP1 Q9NUW8 2/20 0.57
PABPC1 P11940 1/20 0.57
RAB9A P51151 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31218585 1.00 MAPT (0.63) MAPTSMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL3418821 0.95 TERT (0.61) MAPTSMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL3416154 0.94 TERT (0.62) MAPTSMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL31218593 0.91 MAPT (0.71) MAPTSMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL13434540 0.91 TERT (0.57) MAPTSMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL14882640 0.90 TERT (0.56) MAPTSMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL7557626 0.89 MALT1 (0.62) MAPTSMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL31218590 0.89 MALT1 (0.62) MAPTSMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL29587040 0.89 MALT1 (0.62) MAPTSMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL3415549 0.88 NSD2 (0.62) MAPTSMN1; SMN2MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100062429-A1 Fluorochromes for organelle tracing and multi-color imaging ENZO LIFE SCIENCES, INC. 2010-03-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100062429-A1 Fluorochromes for organelle tracing and multi-color imaging MFN2, TFEB, NDC1 MAPT 469/4885SMN1; SMN2 2076/4885MEN1 1731/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.